title: Is executive control used to compensate for involuntary movements in levodopa-induced dyskinesia?
authors.forename: Adam R
authors.initials: AR
authors.lastname: Aron
authors.forename: Jose
authors.initials: J
authors.lastname: Obeso
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects*; D001931:Brain Mapping; D004409:Dyskinesia, Drug-Induced / Q000473:pathology*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D009043:Motor Activity / Q000502:physiology*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000473:pathology*; D017397:Prefrontal Cortex / Q000098:blood supply* / Q000473:pathology*
chemical_list: D000978:Antiparkinson Agents; D007980:Levodopa